93 related articles for article (PubMed ID: 27087660)
1. Application of constrained aza-valine analogs for Smac mimicry.
Chingle R; Ratni S; Claing A; Lubell WD
Biopolymers; 2016 May; 106(3):235-44. PubMed ID: 27087660
[TBL] [Abstract][Full Text] [Related]
2. Smac mimicry and the conformational flexibility of a sweet friend.
Biopolymers; 2016 May; 106(3):234. PubMed ID: 27163583
[No Abstract] [Full Text] [Related]
3. Design and synthesis of novel azapeptide activators of apoptosis mediated by caspase-9 in cancer cells.
Bourguet CB; Boulay PL; Claing A; Lubell WD
Bioorg Med Chem Lett; 2014 Aug; 24(15):3361-5. PubMed ID: 24986663
[TBL] [Abstract][Full Text] [Related]
4. Azapeptide Synthesis Methods for Expanding Side-Chain Diversity for Biomedical Applications.
Chingle R; Proulx C; Lubell WD
Acc Chem Res; 2017 Jul; 50(7):1541-1556. PubMed ID: 28598597
[TBL] [Abstract][Full Text] [Related]
5. Azopeptides: Synthesis and Pericyclic Chemistry.
Chingle R; Lubell WD
Org Lett; 2015 Nov; 17(21):5400-3. PubMed ID: 26509791
[TBL] [Abstract][Full Text] [Related]
6. Structure-based design, synthesis, and evaluation of conformationally constrained mimetics of the second mitochondria-derived activator of caspase that target the X-linked inhibitor of apoptosis protein/caspase-9 interaction site.
Sun H; Nikolovska-Coleska Z; Yang CY; Xu L; Tomita Y; Krajewski K; Roller PP; Wang S
J Med Chem; 2004 Aug; 47(17):4147-50. PubMed ID: 15293984
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a heterodimeric Smac-based peptide that features sequences specific to both the BIR2 and BIR3 domains of the X-linked inhibitor of apoptosis protein.
Speer KF; Cosimini CL; Splan KE
Biopolymers; 2012; 98(2):122-30. PubMed ID: 22020922
[TBL] [Abstract][Full Text] [Related]
8. Design of small-molecule Smac mimetics as IAP antagonists.
Wang S
Curr Top Microbiol Immunol; 2011; 348():89-113. PubMed ID: 21072626
[TBL] [Abstract][Full Text] [Related]
9. A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells.
Bockbrader KM; Tan M; Sun Y
Oncogene; 2005 Nov; 24(49):7381-8. PubMed ID: 16044155
[TBL] [Abstract][Full Text] [Related]
10. Rational design, synthesis and characterization of potent, drug-like monomeric Smac mimetics as pro-apoptotic anticancer agents.
Bianchi A; Ugazzi M; Ferrante L; Lecis D; Scavullo C; Mastrangelo E; Seneci P
Bioorg Med Chem Lett; 2012 Mar; 22(6):2204-8. PubMed ID: 22342627
[TBL] [Abstract][Full Text] [Related]
11. Bivalent Smac mimetics with a diazabicyclic core as highly potent antagonists of XIAP and cIAP1/2 and novel anticancer agents.
Peng Y; Sun H; Lu J; Liu L; Cai Q; Shen R; Yang CY; Yi H; Wang S
J Med Chem; 2012 Jan; 55(1):106-14. PubMed ID: 22148838
[TBL] [Abstract][Full Text] [Related]
12. Solid phase synthesis of Smac/DIABLO-derived peptides using a 'Safety-Catch' resin: identification of potent XIAP BIR3 antagonists.
Elsawy MA; Martin L; Tikhonova IG; Walker B
Bioorg Med Chem; 2013 Sep; 21(17):5004-11. PubMed ID: 23886811
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for bivalent Smac-mimetics recognition in the IAP protein family.
Cossu F; Milani M; Mastrangelo E; Vachette P; Servida F; Lecis D; Canevari G; Delia D; Drago C; Rizzo V; Manzoni L; Seneci P; Scolastico C; Bolognesi M
J Mol Biol; 2009 Sep; 392(3):630-44. PubMed ID: 19393243
[TBL] [Abstract][Full Text] [Related]
14. Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism.
Allensworth JL; Sauer SJ; Lyerly HK; Morse MA; Devi GR
Breast Cancer Res Treat; 2013 Jan; 137(2):359-71. PubMed ID: 23225169
[TBL] [Abstract][Full Text] [Related]
15. Role of Smac/DIABLO in cancer progression.
Martinez-Ruiz G; Maldonado V; Ceballos-Cancino G; Grajeda JP; Melendez-Zajgla J
J Exp Clin Cancer Res; 2008 Sep; 27(1):48. PubMed ID: 18822137
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Smac promotes Cisplatin-induced apoptosis by activating caspase-3 and caspase-9 in lung cancer A549 cells.
Qin S; Yang C; Wang X; Xu C; Li S; Zhang B; Ren H
Cancer Biother Radiopharm; 2013 Mar; 28(2):177-82. PubMed ID: 23252748
[TBL] [Abstract][Full Text] [Related]
17. Azapeptides and their therapeutic potential.
Proulx C; Sabatino D; Hopewell R; Spiegel J; García Ramos Y; Lubell WD
Future Med Chem; 2011 Jul; 3(9):1139-64. PubMed ID: 21806378
[TBL] [Abstract][Full Text] [Related]
18. Smac induces cytochrome c release and apoptosis independently from Bax/Bcl-x(L) in a strictly caspase-3-dependent manner in human carcinoma cells.
Hasenjäger A; Gillissen B; Müller A; Normand G; Hemmati PG; Schuler M; Dörken B; Daniel PT
Oncogene; 2004 Jun; 23(26):4523-35. PubMed ID: 15064710
[TBL] [Abstract][Full Text] [Related]
19. Benzophenone semicarbazone protection strategy for synthesis of aza-glycine containing aza-peptides.
Bourguet CB; Sabatino D; Lubell WD
Biopolymers; 2008; 90(6):824-31. PubMed ID: 18844293
[TBL] [Abstract][Full Text] [Related]
20. Dual action Smac mimetics-zinc chelators as pro-apoptotic antitumoral agents.
Manzoni L; Gornati D; Manzotti M; Cairati S; Bossi A; Arosio D; Lecis D; Seneci P
Bioorg Med Chem Lett; 2016 Oct; 26(19):4613-4619. PubMed ID: 27578248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
